Stock LUN LUNDBECK
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Lundbeck Nasdaq Copenhagen

Equities

LUN

DK0061804697

Market Closed - Nasdaq Copenhagen
Other stock markets
 10:59:33 2024-05-03 am EDT 		5-day change 1st Jan Change
28.75 DKK -0.17% Intraday chart for Lundbeck +3.04% -16.76%
Apr. 09 H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy MT
Apr. 09 Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy
MT
Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD
CI
EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia
MT
Otsuka Pharmaceutical Europe Ltd. and H. Lundbeck A/S Announces Approval in the EU for the Maintenance Treatment of Schizophrenia
CI
H. Lundbeck A/S Approves Dividend for the Accounting Year 2023
CI
H. Lundbeck A/S Announces Potential First-In-Class Therapy for Migraine Prevention Enters Advanced Clinical Stage
CI
H. Lundbeck A/S Proposes Dividend for the Accounting Year 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HLUN B Stock
  4. LUN Stock
  5. News Lundbeck
  6. Highlights